术前黏膜下注射曲马多对症状性不可逆性牙髓炎下颌磨牙下牙槽神经阻滞成功率的影响:一项随机双盲安慰剂对照临床试验
这项随机双盲安慰剂对照临床试验纳入42例症状性不可逆性牙髓炎下颌磨牙患者,比较术前黏膜下注射50 mg曲马多与安慰剂对下牙槽神经阻滞成功率的影响。曲马多组下牙槽神经阻滞成功率为57%,安慰剂组为29%,组间差异未达统计学显著(P=0.06);但在开髓洞型制备时,曲马多组的麻醉成功率显著优于安慰剂组(P=0.03)。
要点
- 42例症状性不可逆性牙髓炎下颌磨牙患者随机分为曲马多组(n=21)和安慰剂组(n=21)。
- 曲马多组下牙槽神经阻滞成功率57% vs 安慰剂组29%,差异未达统计学显著(P=0.06)。
- 开髓洞型制备时曲马多组麻醉成功率显著优于安慰剂组(P=0.03)。
核心结论
- 术前黏膜下注射50 mg曲马多可显著改善症状性不可逆性牙髓炎下颌磨牙在开髓洞型制备时使用4%阿替卡因(含1:100 000肾上腺素)行下牙槽神经阻滞的麻醉成功率,优于安慰剂。
研究设计与样本
- 随机双盲安慰剂对照临床试验,纳入42例诊断为症状性不可逆性牙髓炎的下颌磨牙患者,随机分为曲马多组(n=21)和安慰剂组(n=21)。
主要发现
- 曲马多组下牙槽神经阻滞成功率为57%,安慰剂组为29%,组间差异未达统计学显著(P=0.06)。
- 开髓洞型制备时,曲马多组麻醉成功率显著优于安慰剂组(P=0.03)。
关键数值与推荐
- 曲马多组经下颌浸润注射50 mg曲马多(1 mL),安慰剂组经相同方式注射1 mL生理盐水,10分钟后所有患者接受4%阿替卡因(含1:100 000肾上腺素)下牙槽神经阻滞。
- 局部麻醉后等待10分钟,连续进行三项测试评估牙髓麻醉:电牙髓测试连续两次阴性反应、冷测试阳性或阴性反应、开髓洞型制备时无疼痛;仅当患者在这些测试中均无疼痛时,下牙槽神经阻滞才被视为成功。
- 采用卡方频数检验和Fisher精确检验分析定性变量,独立样本Mann-Whitney U检验及双因素方差分析用于两个以上独立样本。
临床怎么用
- 原文结论认为术前黏膜下注射50 mg曲马多可显著改善症状性不可逆性牙髓炎下颌磨牙在开髓洞型制备时下牙槽神经阻滞的成功率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: This randomized, double-blind, placebo-controlled, clinical trial was designed to improve the success of inferior alveolar nerve blocks (IANB) in mandibular molars with symptomatic irreversible pulpitis (SIP) by means of preoperative submucosal administration of 50 mg tramadol. METHODOLOGY: Forty-two patients with a mandibular molar diagnosed with SIP took part in the trial. Patients were assigned randomly to one of two groups: tramadol group (n = 21), who received 50 mg tramadol in 1 mL by mandibular infiltration, and a placebo group (n = 21), who received 1 mL of normal saline administered to the affected tooth by the same means. Ten minutes later, all patients received an IANB with 4% articaine with epinephrine 1 : 100 000. A 10-min waiting time was established after local anaesthetic (LA) administration before carrying out three consecutive tests to assess anaesthesia of the pulp, that is two consecutive negative responses to an electric pulp test, positive or negative response to a cold test and no pain during access cavity preparation. IANB was considered successful only if the patient did not experience pain arising from these tests. Data were analysed by the Chi-squared frequency test and the Fisher's exact test, for qualitative variables, Mann-Whitney U-test for independent samples and two-way anova for more than two independent samples. RESULTS: In the tramadol group IANB was achieved successfully in 57% of the sample, whilst the placebo group obtained 29%. The difference between groups was not significant (P = 0.06). When performing endodontic access, the anaesthetic success rate was significantly in favour of tramadol (P = 0.03). CONCLUSIONS: Preoperative submucosal administration of 50 mg tramadol in mandibular molars with SIP significantly improved the success of IANB using 4% articaine with 1 : 100 000 epinephrine during access cavity preparation in comparison with a placebo.
引用
- De Pedro-Muñoz A, Mena-Álvarez J. The effect of preoperative submucosal administration of tramadol on the success rate of inferior alveolar nerve block on mandibular molars with symptomatic irreversible pulpitis: a randomized, double-blind placebo-controlled clinical trial. Int Endod J. 2017. PMID: 28214370. doi:10.1111/iej.12755
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。